16th Annual Champions to CureDuchenne Raises Over $400,000 to Fund Duchenne Muscular Dystrophy Research 

“Vintage Vegas for Duchenne” Gala Featured Casino Games, Cocktails, Gourmet Dining, and More to Help Advance Research for the Rare Disease 

 AUSTIN, Texas., April 15, 2025 – CureDuchenne, a leading global nonprofit focused on finding and funding a cure for Duchenne muscular dystrophy, and the Revell family of Austin hosted the 16th annual fundraiser gala, Champions to CureDuchenne: Vintage Vegas for Duchenne, on April 5, 2025. The event raised over $400,000 to benefit CureDuchenne as it accelerates scientific research and pioneers educational programs to care for families affected by Duchenne, a progressive, fatal disease affecting 300,000 worldwide. 

Inspired by the glitz and glamour of the Rat Pack era, this unforgettable evening transported guests back to the sixties with a sophisticated Vegas-style experience. Hundreds of philanthropists, business leaders, and local community members gathered at the University of Texas Golf Club for an elegant cocktail reception, exhilarating live and silent auctions, a gourmet dinner, and an after-hours casino party. The event was presented by Mighty Fine Burgers, Fries & Shakes. 

The Revell family’s personal connection to Duchenne fuels their unwavering commitment to this cause. Tim and Laura Revell learned their two boys, Timothy and Andrew, were diagnosed with Duchenne muscular dystrophy, one of the most common and severe forms of muscular dystrophy, at just two and five years old. Duchenne is a 100% fatal disease that affects 1 in 5,000 boys. Children diagnosed with Duchenne often lose their ability to walk in their early teens and face life-threatening complications in their twenties. When the Revells received this devastating diagnosis, resources and treatment options were extremely limited. Determined to create change, they partnered with CureDuchenne and began organizing fundraising events to drive research forward. Their annual galas, marathons, and community gatherings have raised more than $8 million to date, bringing hope to families impacted by Duchenne. “We are so grateful to the Austin community for their support of our family and the thousands facing Duchenne across the country and around the world,” said Tim Revell. “Through events like Champions to CureDuchenne, we will fund groundbreaking research that is moving us closer to a cure. We won’t stop until there is a cure for every family affected by this disease.” “The dedication of the Revell family and the Austin community has played a vital role in the progress we’ve made on behalf of those facing Duchenne muscular dystrophy,” said CureDuchenne founder and CEO Debra Miller. “While we have made incredible strides in research, many individuals with Duchenne—including the Revell boys and my own son—are still waiting for life-changing treatments. This event will help us continue our momentum to bring a cure within reach.” 

For more information and ways to support CureDuchenne, please visit cureduchenne.org. 

About CureDuchenne Over twenty years ago, CureDuchenne was created with one goal: to find and fund a cure for Duchenne muscular dystrophy, one of the most common and severe forms of muscular dystrophy. Today, CureDuchenne is recognized as a global leader in research, patient care and innovation for improving and extending the lives of those with Duchenne. CureDuchenne’s innovative venture philanthropy model has advanced transformative treatments for Duchenne muscular dystrophy, including 18 projects that advanced to human clinical trials and multiple projects to overcome the limitations of exon-skipping and gene therapy. In addition, CureDuchenne contributed early funding to the first FDA-approved Duchenne 

drug, pioneered the first and only Duchenne physical and occupational therapist certification program and created an innovative biobank and data registry, accelerating research toward a cure. For more information on how to help raise awareness and funds needed for research, please visit cureduchenne.org. 

###